According to the findings of a case-matched study, Roux-en-Y gastric bypass (RYGBP) provides superior, more rapid weight loss than gastric banding (GB) and results in lower long-term complication and comorbidity rates, although it is associated with a higher early morbidity rate….

It has been said that, “People cannot influence their motivation and actions very well if they do not pay adequate attention to their own performances, the conditions under which they occur, and the immediate and distal effects they produce.” Nowhere is this more evident when we are talking about adolescents …

Edited by Frank J. Snoek and T. Chas Skinner Diabetes in Adolescents   2.3 Individual Interventions (Part 2 of 2) Process of change Diabetes poses considerable demands on the young person’s coping, self-esteem, mood and quality of life.

In this week’s Homerun Slides, we continue with Part 4 of our series from Dr. Stanley Schwartz on An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes. This week’s topics include a look at Pioglitazone, the Natural History of Type 2 Diabetes – Insulin Secretion, and the CV Benefits of …

Over the past two years there have been numerous postponements of the enactment of Medicare’s sustainable growth rate (SGR) formula for physician pay. The SRG was an original attempt to reduce the reimbursements to physicians for Medicare patients. These reductions have now added up to a whopping 27%. We have …

Warning Letter Issued by FDA to J&J for Delayed Reporting for Insulin Pump Problems See this week’s Item #11.

OneTouch®Verio The new OneTouch(R) Verio(TM)IQ System with PatternAlert ™ technology is the first blood glucose meter to look for high and low patterns, and provide on-screen alerts. The new technology helps make it fast and easy to zero in on patterns of highs and lows so patients can take action …

The FDA has notified the company that the new Abbott Freestyle test strip has been cleared for use with the OmniPod system. The companies are in the midst of updating the product label and will be communicating with customers once that has been completed, probably next week. The latest version …

Obese patients with or without diabetes who took a minimum dosage of the appetite-suppressing glucagon-like peptide-1 hormone for at least 20 weeks lost more weight than people in control groups from a review of 25 studies in the British Medical Journal. Researchers also noted improvements in blood pressure and total …

The New York City health department launched a subway advertising campaign to warn people about the health risks of eating supersize portions. The restaurant industry said it is being unfairly attacked, but the department’s Gretchen Van Wye said at-home portions and even plates are larger than they were in decades …